Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Brazil will encourage partnership between academia and industry through joint ventures, backed up by favorable tax incentives, but such measures rely on greater industry involvement.
Competitive intelligence (CI) gathering is essential to developing a biotech firm's business strategy, but few startups have sufficient support systems in place to do CI effectively. This article, the first of two on the topic, addresses why it is important and how to do it.
Several UK universities have given exclusive rights to finance their startups to specialist seed investors, but this monopoly may not be the only way to finance early-stage biotech startups.
A new program to train workers in the skills required to work in the biotech sector offer a career opportunity to some but are still too few and far between.
As the complexity and expense of clinical development grows, there is considerable pressure on companies to maximize the potential of a clinical study.
Leveraging a background in vaccines and leadership skills learned in the Army, Wayne Hockmeyer made a mid-career shift and built a biotech juggernaut. He is now onto his third career.
Without a strategy to guide the development of their IP portfolios, companies may waste valuable resources and miss opportunities to protect valuable inventions.
University licensing is likely to increase as pharma looks to supplement drug pipelines, and venture capitalists broaden their focus to platform technologies.
